Pay in 4 interest-free payments of $7.37 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
The published policy permits cancellation and limited refunds in specific circumstances: a full refund if a medical provider disqualifies you before medication is ordered, but no refund once it's ordered, and rendered clinical services are non-refundable regardless
Zepbound Switching: How to Transition From or To Other GLP-1/GIP Drugs Safely At a glance Drug / Zepbound (tirzepatide), Eli Lilly Drug class / Dual GIP and GLP-1 receptor agonist Approved indication / Chronic weight management in adults with BMI 30, or 27 with one weight-related comorbidity Dosing frequency / Once weekly subcutaneous injection Starting dose / 2.5 mg weekly, escalated every 4 weeks Maximum dose / 15 mg weekly Key trial / SURMOUNT-1 (N=2,539): 20.9% mean body-weight loss at 72 weeks on 15 mg Half-life / Approximately 5 days (supports once-weekly dosing) Common switch scenarios / Semaglutide to tirzepatide, liraglutide to tirzepatide, tirzepatide to oral semaglutide FDA approval date / November 8, 2023 (weight management indication) How Zepbound Works: Mechanism at the Receptor Level Zepbound binds both the glucose-dependent insulinotropic polypeptide (GIP) receptor and the glucagon-like peptide-1 (GLP-1) receptor
there are so many options for you to choose from
Well help you: Understand how the benefits of semaglutide fit into your overall health Navigate choices like alcohol, travel, stress, and sleep Stay accountable with ongoing support Adjust your plan as your needs change Explore alternative treatments if needed You dont have to figure this out on your own
US$ 28.20
US$ 22.79
US$ 20.58
